Stock Price of VCA Inc. (WOOF) Increases 0.04%

VCA Inc. s in-depth stock price analysis indicates that the stock price has rallied 39.87% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 27.93% . Looking at the past 52 week period, the stock price is up at 81.71% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of VCA Inc. has a positive value of 19 compared to overall market. Stocks of VCA Inc. (NASDAQ:WOOF) rallied by 0.04% during the past week but lost 0.61% on a 4-week basis. The stocks are negative as compared to the S&P 500 for the past week with a loss of 0.76%. VCA Inc. (NASDAQ:WOOF) has underperformed the index by 2.39% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

VCA Inc. (NASDAQ:WOOF) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.09 points or 0.1% at $90.69 with 1,145,731 shares getting traded. Post opening the session at $90.73, the shares hit an intraday low of $90.645 and an intraday high of $90.84 and the price was in this range throughout the day. The company has a market cap of $7,398 million and the number of outstanding shares has been calculated to be 81,573,526 shares. The 52-week high of VCA Inc. (NASDAQ:WOOF) is $91.58 and the 52-week low is $45.55.

VCA Inc Last issued its quarterly earnings results on Feb 9, 2017. The company reported $0.58 EPS for the quarter, missing the analyst consensus estimate by $ -0.02. Analyst had a consensus of $0.60. The company had revenue of $643.10 million for the quarter, compared to analysts expectations of $642.85 million. The companys revenue was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.50 EPS.

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.VCA Inc was Downgraded by CL King to Neutral on Jan 26, 2017. VCA Inc was Downgraded by Credit Suisse to Neutral on Jan 11, 2017. VCA Inc was Downgraded by Raymond James to Mkt Perform on Jan 10, 2017. VCA Inc was Upgraded by Raymond James to Strong Buy on Jan 3, 2017.

Company has reported several Insider transactions to the SEC, on Sep 19, 2016, Arthur J Antin (COO & Senior VP) sold 34,000 shares at 69.03 per share price.On Sep 8, 2016, Josh Drake (President, Antech Diagnostics) sold 14,584 shares at 72.01 per share price.On Sep 6, 2016, Tomas W Fuller (CFO, VP & Secretary) sold 47,544 shares at 70.59 per share price.

VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California.

VCA

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.